António Pêgo

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

José Baselga, Patricia Gómez, Richard Greil et al. · Journal of Clinical Oncology · 2013 · 351 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract PD01-01: Cetuximab + Cisplatin in Estrogen Receptor-Negative, Progesterone Receptor-Negative, HER2-Negative (Triple-Negative) Metastatic Breast Cancer: Results of the Randomized Phase II BALI-1 Trial

José Baselga, Salomon M. Stemmer, António Pêgo et al. · Cancer Research · 2010 · 49 citations

Medicine, Oncology, Pharmacology +17

Prognostic factors for early relapse in non-metastatic triple negative breast cancer — real world data

R. Félix Soares, Ana Rita Garcia, Ana Raquel Monteiro et al. · Reports of Practical Oncology & Radiotherapy · 2021 · 14 citations · Full text

Medicine, Oncology, Breast Oncology +13